Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|March 9, 2017
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current EvidenceJuwon Yim, Jordan R Smith, Michael J Rybak
Pharmacotherapy|September 6, 2019
Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the EpoxideTrang D Trinh, Jordan R Smith, Michael J Rybak
Pharmacotherapy|February 16, 2020
Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative InfectionsJordan R Smith, Jeffrey M Rybak, Kimberly C Claeys
Infectious Diseases and Therapy|September 6, 2015
Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive InfectionsJordan R Smith, Karrine D Roberts, Michael J Rybak
Antimicrobial Agents and Chemotherapy|February 3, 2016
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant EnterococciJordan R Smith, Juwon Yim, Animesh Raut, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic modelsJordan R Smith, Katie E Barber, Animesh Raut, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2015
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolidKatie E Barber, Jordan R Smith, Animesh Raut, et al.
Current Infectious Disease Reports|August 29, 2014
High-dose daptomycin therapy for staphylococcal endocarditis and when to apply itJordan R Smith, Kimberly C Claeys, Katie E Barber, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 2017
Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental studyJordan R Smith, Jeremy J Frens, Cynthia B Snider, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic modelsJordan R Smith, Katie E Barber, Jessica Hallesy, et al.
Pageof 3